Literature DB >> 20194499

G alpha(q)-mediated activation of GRK2 by mechanical stretch in cardiac myocytes: the role of protein kinase C.

Ricky Malhotra1, Karen M D'Souza, Michelle L Staron, Konstantin G Birukov, Ilona Bodi, Shahab A Akhter.   

Abstract

G protein-coupled receptor kinase-2 (GRK2) is a critical regulator of beta-adrenergic receptor (beta-AR) signaling and cardiac function. We studied the effects of mechanical stretch, a potent stimulus for cardiac myocyte hypertrophy, on GRK2 activity and beta-AR signaling. To eliminate neurohormonal influences, neonatal rat ventricular myocytes were subjected to cyclical equi-biaxial stretch. A hypertrophic response was confirmed by "fetal" gene up-regulation. GRK2 activity in cardiac myocytes was increased 4.2-fold at 48 h of stretch versus unstretched controls. Adenylyl cyclase activity was blunted in sarcolemmal membranes after stretch, demonstrating beta-AR desensitization. The hypertrophic response to mechanical stretch is mediated primarily through the G alpha(q)-coupled angiotensin II AT(1) receptor leading to activation of protein kinase C (PKC). PKC is known to phosphorylate GRK2 at the N-terminal serine 29 residue, leading to kinase activation. Overexpression of a mini-gene that inhibits receptor-G alpha(q) coupling blunted stretch-induced hypertrophy and GRK2 activation. Short hairpin RNA-mediated knockdown of PKC alpha also significantly attenuated stretch-induced GRK2 activation. Overexpression of a GRK2 mutant (S29A) in cardiac myocytes inhibited phosphorylation of GRK2 by PKC, abolished stretch-induced GRK2 activation, and restored adenylyl cyclase activity. Cardiac-specific activation of PKC alpha in transgenic mice led to impaired beta-agonist-stimulated ventricular function, blunted cyclase activity, and increased GRK2 phosphorylation and activity. Phosphorylation of GRK2 by PKC appears to be the primary mechanism of increased GRK2 activity and impaired beta-AR signaling after mechanical stretch. Cross-talk between hypertrophic signaling at the level of PKC and beta-AR signaling regulated by GRK2 may be an important mechanism in the transition from compensatory ventricular hypertrophy to heart failure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20194499      PMCID: PMC2859538          DOI: 10.1074/jbc.M110.109272

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

Review 1.  Cytoplasmic signaling pathways that regulate cardiac hypertrophy.

Authors:  J D Molkentin; G W Dorn
Journal:  Annu Rev Physiol       Date:  2001       Impact factor: 19.318

2.  Regulation of membrane targeting of the G protein-coupled receptor kinase 2 by protein kinase A and its anchoring protein AKAP79.

Authors:  M Cong; S J Perry; F T Lin; I D Fraser; L A Hu; W Chen; J A Pitcher; J D Scott; R J Lefkowitz
Journal:  J Biol Chem       Date:  2001-01-22       Impact factor: 5.157

3.  Adenovirus-delivered short hairpin RNA targeting PKCalpha improves contractile function in reconstituted heart tissue.

Authors:  Ali El-Armouche; Jasmin Singh; Hiroshi Naito; Katrin Wittköpper; Michael Didié; Alexander Laatsch; Wolfram-Hubertus Zimmermann; Thomas Eschenhagen
Journal:  J Mol Cell Cardiol       Date:  2007-06-07       Impact factor: 5.000

4.  Cardiac betaARK1 upregulation induced by chronic salt deprivation in rats.

Authors:  G Iaccarino; E Barbato; E Cipolleta; A Esposito; A Fiorillo; W J Koch; B Trimarco
Journal:  Hypertension       Date:  2001-08       Impact factor: 10.190

5.  Phosphorylation of GRK2 by protein kinase C abolishes its inhibition by calmodulin.

Authors:  C Krasel; S Dammeier; R Winstel; J Brockmann; H Mischak; M J Lohse
Journal:  J Biol Chem       Date:  2000-10-19       Impact factor: 5.157

6.  MAPK-dependent degradation of G protein-coupled receptor kinase 2.

Authors:  Ana Elorza; Petronila Penela; Susana Sarnago; Federico Mayor
Journal:  J Biol Chem       Date:  2003-05-08       Impact factor: 5.157

7.  Gene expression pattern in biomechanically stretched cardiomyocytes: evidence for a stretch-specific gene program.

Authors:  Derk Frank; Christian Kuhn; Benedikt Brors; Christiane Hanselmann; Mark Lüdde; Hugo A Katus; Norbert Frey
Journal:  Hypertension       Date:  2007-12-24       Impact factor: 10.190

8.  PKC alpha regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase1/2 (ERK1/2).

Authors:  Julian C Braz; Orlando F Bueno; Leon J De Windt; Jeffery D Molkentin
Journal:  J Cell Biol       Date:  2002-02-25       Impact factor: 10.539

9.  Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach.

Authors:  Qinghang Liu; Xiongwen Chen; Scott M Macdonnell; Evangelia G Kranias; John N Lorenz; Michael Leitges; Steven R Houser; Jeffery D Molkentin
Journal:  Circ Res       Date:  2009-06-25       Impact factor: 17.367

Review 10.  Protein kinase C in heart failure: a therapeutic target?

Authors:  Suresh Selvaraj Palaniyandi; Lihan Sun; Julio Cesar Batista Ferreira; Daria Mochly-Rosen
Journal:  Cardiovasc Res       Date:  2009-01-24       Impact factor: 13.081

View more
  17 in total

Review 1.  Reverse remodeling in heart failure--mechanisms and therapeutic opportunities.

Authors:  Norimichi Koitabashi; David A Kass
Journal:  Nat Rev Cardiol       Date:  2011-12-06       Impact factor: 32.419

Review 2.  Electrical and mechanical stimulation of cardiac cells and tissue constructs.

Authors:  Whitney L Stoppel; David L Kaplan; Lauren D Black
Journal:  Adv Drug Deliv Rev       Date:  2015-07-30       Impact factor: 15.470

Review 3.  Protein kinase C mechanisms that contribute to cardiac remodelling.

Authors:  Alexandra C Newton; Corina E Antal; Susan F Steinberg
Journal:  Clin Sci (Lond)       Date:  2016-09-01       Impact factor: 6.124

Review 4.  An updated review of mechanotransduction in skin disorders: transcriptional regulators, ion channels, and microRNAs.

Authors:  Jing Wang; Yifan Zhang; Ning Zhang; Chuandong Wang; Tanja Herrler; Qingfeng Li
Journal:  Cell Mol Life Sci       Date:  2015-02-15       Impact factor: 9.261

Review 5.  Sub-cellular localization specific SUMOylation in the heart.

Authors:  Nhat-Tu Le; James F Martin; Keigi Fujiwara; Jun-Ichi Abe
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-01-24       Impact factor: 5.187

6.  Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-κB.

Authors:  Suresh Kumar Verma; Prasanna Krishnamurthy; David Barefield; Neha Singh; Rajesh Gupta; Erin Lambers; Melissa Thal; Alexander Mackie; Eneda Hoxha; Veronica Ramirez; Gangjian Qin; Sakthivel Sadayappan; Asish K Ghosh; Raj Kishore
Journal:  Circulation       Date:  2012-06-15       Impact factor: 29.690

Review 7.  Cardiac actions of protein kinase C isoforms.

Authors:  Susan F Steinberg
Journal:  Physiology (Bethesda)       Date:  2012-06

Review 8.  The evolving impact of g protein-coupled receptor kinases in cardiac health and disease.

Authors:  Priscila Y Sato; J Kurt Chuprun; Mathew Schwartz; Walter J Koch
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

Review 9.  Computational models reduce complexity and accelerate insight into cardiac signaling networks.

Authors:  Jason H Yang; Jeffrey J Saucerman
Journal:  Circ Res       Date:  2011-01-07       Impact factor: 17.367

Review 10.  Protein kinase Cα as a heart failure therapeutic target.

Authors:  Qinghang Liu; Jeffery D Molkentin
Journal:  J Mol Cell Cardiol       Date:  2010-10-16       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.